Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

1. Ravassa, S.
2. López, B.
3. Ferreira, J.P.
4. Girerd, N.
5. Bozec, E.
6. Pellicori, P.
7. Mariottoni, B.
8. Cosmi, F.
9. Hazebroek, M.
10. Verdonschot, J.A.J.
11. Cuthbert, J.
12. Petutschnigg, J.
13. Moreno, M.U.
14. Heymans, S.
15. Staessen, J.A.
16. Pieske, B.
17. Edelmann, F.
18. Clark, A.L.
19. Cleland, J.G.F.
20. Zannad, F.
21. Díez, J.
22. González, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/EJHF.2394 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus